Hepatitis B in Pregnancy

Clinics in Liver Disease

Volumn 11, Issue 4, 2007, Pages 945-963

  Gambarin Gelwan, Maya ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; LAMIVUDINE; VIRUS VACCINE;

ACTIVE IMMUNIZATION; BREAST FEEDING EDUCATION; DISEASE CARRIER; DISEASE COURSE; DISEASE SEVERITY; DISEASE TRANSMISSION; DRUG EFFICACY; DRUG SAFETY; HEALTH CARE SYSTEM; HEALTH PROGRAM; HEPATITIS B; HUMAN; IMMUNE STATUS; IMMUNOPROPHYLAXIS; INFECTION PREVENTION; INFECTION RISK; LIVER CELL CARCINOMA; LIVER FUNCTION; LIVER TRANSPLANTATION; MONOTHERAPY; OUTCOME ASSESSMENT; PASSIVE IMMUNIZATION; PATIENT SAFETY; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PREVALENCE; REVIEW; RISK ASSESSMENT; TREATMENT OUTCOME; TREATMENT PLANNING;

CARRIER STATE; DISEASE TRANSMISSION, VERTICAL; FEMALE; HEPATITIS B E ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; IMMUNOGLOBULINS; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

EID: 35548959064     PISSN: 10893261     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cld.2007.08.004     Document Type: Review

References (108)

1. Lee W.M. Hepatitis B virus infection. N Engl J Med 337 24 (1997) 1733-1745
2. Lok A.S. Chronic hepatitis B. N Engl J Med 346 22 (2002) 1682-1683
3. Yao J.L. Perinatal transmission of hepatitis B virus infection and vaccination in China. Gut 38 Suppl 2 (1996) S37-S38
4. Euler G., Wooten K., Baughman A., et al. Hepatitis B surface antigen prevalence among pregnant women in urban areas: implications for testing, reporting, and preventing perinatal transmission. Pediatrics 111 5 part2 (2003) 1192-1197
5. Chang M.H. Chronic hepatitis virus infection in children. J Gastroenterol Hepatol 13 5 (1998) 541-548
6. Stevens C.E., Beasley R.P., Tsui J., et al. Vertical transmission of hepatitis B antigen in Taiwan. N Engl J Med 292 15 (1975) 771-774
7. Beasley R.P., Hwang L.Y., Lin C.C., et al. Hepatitis B immune globulin (HBIG) efficacy in the interruption of perinatal transmission of hepatitis B virus carrier state. Initial report of a randomized double-blind placebo-controlled trial. Lancet 2 8243 (1981) 388-393
8. Wong V.C., Ip H.M., Reesink H.W., et al. Prevention of the HBsAg carrier state on newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis-B vaccine and hepatitis-B immunoglobulin. Double-blind randomized placebo-controlled study. Lancet 1 8383 (1984) 921-926
9. del Canho R., Grosheide P.M., Schalm S.W., et al. Failure of neonatal hepatitis B vaccination: the role of HBV-DNA levels in hepatitis B carrier mothers and HLA antigens in neonates. J Hepatol 20 4 (1994) 483-486
10. Oon C.J., and Chen W.N. Current aspects of hepatitis B surface antigen mutants in Singapore. J Viral Hepat 5 Suppl 2 (1998) 17-23
11. Tovo P.A., Lazier L., and Versace A. Hepatitis B virus and hepatitis C virus infections in children. Curr Opin Infect Dis 18 3 (2005) 261-266
12. McMahon B.J., Alward W.L., Hall D.B., et al. Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state. J Infect Dis 151 4 (1985) 599-603
13. Hyams K.C. Risk of chronicity following acute hepatitis B virus infection: a review. Clin Infect Dis 20 4 (1995) 992-1000
14. West D.J., and Margolis H.S. Prevention of hepatitis B virus infection in the United States: a pediatric perspective. Pediatr Infect Dis J 11 10 (1992) 866-874
15. Beasley R.P., Hwang L.Y., Lin C.C., et al. Hepatocellular carcinoma and hepatitis B virus: a prospective study of 22,707 men in Taiwan. Lancet 2 8256 (1981) 1129-1133
16. McMahon B.J., Alberts S.R., Wainwright R.B., et al. Hepatitis B-related sequelae. Prospective study in 1400 hepatitis B surface antigen-positive Alaska native carriers. Arch Intern Med 150 5 (1990) 1051-1054
17. Shapiro C.N. Epidemiology of hepatitis B. Pediatr Infect Dis J 12 5 (1993) 433-437
18. Centers for Disease Control and Prevention. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents. MMWR Recomm Rep 54 RR-16 (2005) 1-31
19. Lok A.S., McMahon B.J., and Chronic hepatitis B. AASLD practice guidelines. Hepatology 45 2 (2007) 507-539
20. Cowan S.A., Bagdonaite J., and Qureshi K. Universal hepatitis B screening of pregnant women in Denmark ascertains substantial additional infections: results from the first five months. Euro Surveill 11 6 (2006) E060608.3
21. Okada K., Kamiyama I., Inomata M., et al. e antigen and anti-e in the serum of asymptomatic carrier mothers as indicators of positive and negative transmission of hepatitis B virus to their infants. N Engl J Med 294 14 (1976) 746-749
22. Beasley R.P., Trepo C., Stevens C.E., et al. The e antigen and vertical transmission of hepatitis B surface antigen. Am J Epidemiol 105 2 (1977) 94-98
23. Stevens C.E., Toy P.T., Tong M.J., et al. Perinatal hepatitis B virus transmission in the United States: prevention by passive-active immunization. JAMA 253 12 (1985) 1740-1745
24. Guntupalli S.R., and Steingrub J. Hepatic disease and pregnancy: an overview of diagnosis and management. Crit Care Med 33 10 (2005) S332-S339
25. Xu D.Z., Yan Y.P., Choi B.C., et al. Risk factors and mechanism of transplacental transmission of hepatitis B virus: a case-control study. J Med Virol 67 1 (2002) 20-26
26. Towers C.V., Asrat T., and Rumney P. The presence of hepatitis B surface antigen and deoxyribonucleic acid in amniotic fluid and cord blood. Am J Obstet Gynecol 184 7 (2001) 1514-1518
27. Andre F.E., and Zuckerman A.J. Review: protective efficacy of hepatitis B vaccines in neonates. J Med Virol 44 2 (1994) 144-151
28. Lee C., Gong Y., Brok J., et al. Effect of hepatitis B immunization in newborn infants of mothers positive for hepatitis B surface antigen: systematic review and meta-analysis. BMJ 332 7537 (2006) 328-336
29. Tse K., Siu S.L.Y., Yip K.T., et al. Immuno-prophylaxis of babies borne to hepatitis B carrier mothers. Hong Kong Med J 12 5 (2006) 368-374
30. Sloan D., Ramsay M., Prasad L., et al. Prevention of perinatal transmission of hepatitis B to babies at high risk: an evaluation. Vaccine 23 48-9 (2005) 5500-5508
31. Gonzalez-Quintero V.H., Katz D., Pandya-Smith I., et al. Assessing perinatal hepatitis B screening and neonatal prophylaxis in a large, multiethnic county. J Reprod Med 51 2 (2006) 101-108
32. Poland G.A., and Jacobson R.M. Prevention of hepatitis B with the hepatitis B vaccine. N Engl J Med 351 27 (2004) 2832-2838
33. Levy M., and Koren G. Hepatitis B vaccine in pregnancy: maternal and fetal safety. Am J Perinatol 8 3 (1991) 227-232
34. Ornoy A., and Tenenbaum A. Pregnancy outcome following infections by coxsackie, echo, measles, mumps, hepatitis, polio and encephalitis viruses. Reprod Toxicol 21 4 (2006) 446-457
35. Xu Z.Y., Duan S.C., Margolis H.S., et al. Long-term efficacy of active postexposure immunization of infants for prevention of hepatitis B virus infection. United States-People's Republic of China Study Group on Hepatitis B. J Infect Dis 171 1 (1995) 54-60
36. Wang J.S., Zhu Q.R., and Wang X.H. Breastfeeding does not pose any additional risk of immunoprophylaxis failure on infants of HBV carrier mothers. Int J Clin Pract 57 2 (2003) 100-102
37. Wang J.S., Chen H., and Zhu Q.R. Transformation of hepatitis B serological markers in babies born to hepatitis B surface antigen positive mothers. World J Gastroenterol 11 23 (2005) 3582-3585
38. Zhang S.L., Yue Y.F., Bai G.Q., et al. Mechanism of intrauterine infection of hepatitis B virus. World J Gastroenterol 10 3 (2004) 437-438
39. Hadchouel M., Scotto J., Huret J.L., et al. Presence of HBV DNA in spermatozoa: a possible vertical transmission of HBV via germ line. J Med Virol 16 1 (1985) 61-66
40. Wang S., Peng G., Li M., et al. Identification of hepatitis B virus vertical transmission from father to fetus by direct sequencing. Southeast Asian J Trop Med Public Health 34 1 (2003) 106-113
41. Huang J.M., Huang T.H., Qiu H.Y., et al. Effects of hepatitis B virus infection on human sperm chromosomes. World J Gastroenterol 9 4 (2003) 736-740
42. Hann H.W.L., Hann R.S., and Maddrey W.C. Hepatitis B virus infection in 6,130 unvaccinated Korean-Americans surveyed between 1988 and 1990. Am J Gastroenterol 102 4 (2007) 767-772
43. Su H.X., Xu D.Z., Li D., et al. Heterogeneity analysis of the hepatitis B virus genome in intrauterine infection. J Med Virol 77 2 (2005) 180-187
44. Hsu H.Y., Chang M.H., Ni Y.H., et al. Surface gene mutants of hepatitis B virus in infants who develop acute of chronic infections despite immunoprophylaxis. Hepatology 26 3 (1997) 786-791
45. Zhu Q.R., Ge Y.L., Gu S.Q., et al. Relationship between cytokines gene polymorphism and susceptibility to hepatitis B virus intrauterine infection. Chin Med J (Engl) 118 19 (2005) 1604-1609
46. Yu H., Zhu Q.R., Gu S.Q., et al. Relationship between IFN-γ gene polymorphism and susceptibility to intrauterine HBV infection. World J Gastroenterol 12 18 (2006) 2928-2931
47. Milich D.R., Jones J.E., Hughes J.L., et al. Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero?. Proc Natl Acad Sci U S A 87 17 (1990) 6599-6603
48. Milich D., and Liang T.J. Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection. Hepatology 38 5 (2003) 1075-1086
49. Wang J.S., and Zhu Q.R. Infection of the fetus with hepatitis B e antigen via placenta. Lancet 355 9208 (2000) 989
50. Li X.M., Shi M.F., Yang Y.B., et al. Effect of hepatitis B immunoglobulin on interruption of HBV intrauterine infection. World J Gastroenterol 10 21 (2004) 3215-3217
51. Xiao X.M., Li A.Z., Chen X., et al. Prevention of vertical hepatitis B transmission by hepatitis B immunoglobulin in the third trimester of pregnancy. Int J Gynaecol Obstet 96 3 (2007) 167-170 [Epub February 12, 2007]
52. Li X.M., Yang Y.B., Hou H.Y., et al. Interruption of HBV intrauterine transmission: a clinical study. World J Gastroenterol 9 7 (2003) 1501-1503
53. Yuan J., Lin J., Xu A., et al. Antepartum immunoprophylaxis of three doses of hepatitis B immunoglobulin is not effective: a single-center randomized study. J Viral Hepat 13 9 (2006) 597-604
54. Ranger-Rogez S., and Denies F. Hepatitis B mother-to-child transmission. Expert Rev Anti Infect Ther 2 1 (2004) 133-145
55. Rumi M.A., Begum K., Hassan M.S., et al. Detection of hepatitis B surface antigen in pregnant women attending a public hospital for delivery: implications for vaccination strategy in Bangladesh. Am J Trop Med Hyg 59 2 (1998) 318-322
56. Poovorawan Y., Chongsrisawat V., Theamboonlers A., et al. Is there evidence for intrauterine HBV infection in newborns of hepatitis B carrier mothers?. Southeast Asian J Trop Med Public Health 28 2 (1997) 365-369
57. Lai C.L., Chien R.N., Leung N.W.Y., et al. A one-year trial of lamivudine for chronic hepatitis B. N Engl J Med 339 2 (1998) 61-68
58. Kazim S.N., Wakil S.M., Khan L.A., et al. Vertical transmission of hepatitis B virus despite maternal lamivudine therapy. Lancet 359 9316 (2002) 1488-1489
59. Van Zonneveld M., van Nunen A.B., Niesters H.G., et al. Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection. J Viral Hepat 10 4 (2003) 294-297
60. Van Nunen A.B., de Man R.A., Heijtink R.A., et al. Lamivudine in the past 4 weeks of pregnancy to prevent perinatal transmission in highly viremic chronic hepatitis B patients. J Hepatol 32 6 (2000) 1040-1041
61. Xu W.M., Cui C.Y.T., Wang L., et al. Efficacy and safety of lamivudine in late pregnancy for prevention of mother-child transmission of hepatitis B: a multicenter, randomized, double-blind, placebo-controlled study. [abstract]. Hepatology 40 Suppl 1 (2004) 272A
62. Wright T.L., Mamish D., Combs C., et al. Hepatitis B virus and apparent fulminant non-A, non-B hepatitis. Lancet 339 8799 (1992) 952-955
63. van Os H.C., Drogendijk A.C., Fetter W.P., et al. The influence of contamination of culture medium with hepatitis B virus on the outcome of in vitro fertilization pregnancies. Am J Obstet Gynecol 165 1 (1991) 152-159
64. ACOG educational bulletin. Viral hepatitis in pregnancy. Number 248, July 1998. American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet 63 2 (1998) 195-202
65. Mirochnick M., and Capparelli E. Pharmacokinetics of antiretrovirals in pregnant women. Clin Pharmacokinet 43 15 (2004) 1071-1087
66. Johnson M.A., Moore K.H., Yuen G.J., et al. Clinical pharmacokinetics of lamivudine. Clin Pharmacokinet 36 1 (1999) 41-66
67. Ikeda T., Ch'ng T.W., and Oleske J.M. Recommendations in pediatric antiretroviral therapy. Expert Opin Pharmacother 8 2 (2007) 155-166
68. Su G.G., Pan K.H., Zhao N.F., et al. Efficacy and safety of lamivudine treatment for chronic hepatitis B in pregnancy. World J Gastroenterol 10 6 (2004) 910-912
69. Keeffe E.B., Dieterich D.T., Han S.H., et al. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: an update. Clin Gastroenterol Hepatol 4 8 (2006) 936-962 [Epub 2006 July, 14]
70. Chen C.J., Wang L.Y., and Yu M.W. Towards control of hepatitis B in the Asia-Pacific region. Epidemiology of hepatitis B virus infection in the Asia-Pacific region. J Gastroenterol Hepatol 15 Suppl 2 (2000) E3-E6
71. Kwan L.C., Ho Y.Y., and Lee S.S. The declining HBsAg carriage rate in pregnant women in Hong Kong. Epidemiol Infect 119 2 (1997) 281-283
72. Wong S., Chan L.Y., Yu V., et al. Hepatitis B carrier and perinatal outcome in singleton pregnancy. Am J Perinatol 16 9 (1999) 485-488
73. To W.W., Cheung W., and Mok K.M. Hepatitis B surface antigen carrier status and its correlation to gestational hypertension. Aust N Z J Obstet Gynaecol 43 2 (2003) 119-122
74. Pastorek J.G., Miller J.M., and Summers P.R. The effect of hepatitis B antigenemia on pregnancy outcome. Am J Obstet Gynecol 158 3 Pt1 (1988) 486-489
75. Tse K.Y., Ho L.F., and Lao T. The impact of maternal HBsAg carrier status on pregnancy outcomes: a case-control study. J Hepatol 43 5 (2005) 771-775
76. Lao T.T., Tse K.Y., Chan L.Y., et al. HBsAG carrier status and the association between gestational diabetes with increased serum ferritin concentration in Chinese women. Diabetes Care 26 11 (2003) 3011-3016
77. Lin H.H., Chen P.J., Chen D.S., et al. Postpartum subsidence of hepatitis B viral replication in HBeAg-positive carrier mothers. J Med Virol 29 1 (1989) 1-6
78. Almog Y., Klein A., Adler R., et al. Oestrogen suppresses hepatitis B virus expression in male athymic mice transplanted with HBV transfected Hep G-2 cells. Antiviral Res 19 4 (1992) 285-293
79. Söderström A., Norkrans G., and Lindh M. Hepatitis B virus DNA during pregnancy and post partum: aspects on vertical transmission. Scand J Infect Dis 35 11ndash12 (2003) 814-819
80. Lin H.H., Wu W.Y., Kao J.H., et al. Hepatitis B post-partum e antigen clearance in hepatitis B carrier mothers: correlation with viral characteristics. J Gastroenterol Hepatol 21 3 (2006) 605-609
81. Woo D., Cummins M., Davies P.A., et al. Vertical transmission of hepatitis B surface antigen in carrier mothers in two west London hospitals. Arch Dis Child 54 9 (1979) 670-675
82. Chen D.S., Hsu N.H., Sung J.L., et al. The Hepatitis Steering Committee and the Hepatitis Control Committee. A mass vaccination program in Taiwan against hepatitis B virus infection in infants of hepatitis B surface antigen-carrier mothers. JAMA 257 19 (1987) 2597-2603
83. Wong V.C., Lee A.K.Y., and Ip H.M.H. Transmission of hepatitis B antigens from symptom free carrier mothers to the fetus and the infant. Br J Obstet Gynaecol 87 11 (1980) 958-965
84. Beasley R.P., Stevens C.E., Shiao I.S., et al. Evidence against breastfeeding as a mechanism for vertical transmission of hepatitis B. Lancet 2 7938 (1975) 740-741
85. Hill J.B., Sheffield J.S., Kim M.J., et al. Risk of hepatitis B transmission in breast-fed infants of chronic hepatitis B carriers. Obstet Gynecol 99 6 (2002) 1049-1052
86. Tseng R.Y.M., Lam C.W.K., and Tam J. Breastfeeding babies of HBsAg positive mothers. [letter]. Lancet 2 8618 (1988) 1032
87. De Martino M., Appendino C., Resti M., et al. Should hepatitis B surface antigen positive mothers breastfeed?. Arch Dis Child 60 10 (1985) 972-974
88. Gartner L.M., Morton J., Lawrence R.A., et al. American Academy of Pediatrics Section on Breastfeeding. Breastfeeding and the use of human milk. Pediatrics 115 (2005) 496-506
89. Moodley D., Pillay K., Naidoo K., et al. Pharmacokinetics of zidovudine and lamivudine in neonates following coadministration of oral doses every 12 hours. J Clin Pharmacol 41 7 (2001) 732-741
90. El-Serag H.B., and Mason A.C. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 340 10 (1999) 745-750
91. Cobey F.C., and Salem R.R. A review of liver masses in pregnancy and a proposed algorithm for their diagnosis and management. Am J Surg 187 2 (2004) 181-191
92. Imkie M., Myers S.A., Li Y., et al. Fibrolamellar hepatocellular carcinoma arising in a background of focal nodular hyperplasia: a report of 2 cases. J Reprod Med 50 8 (2005) 633-637
93. Nam S.W., Baek J.T., Kang S.B., et al. A case of the hepatocellular carcinoma during the pregnancy and metastasis to the left atrium. Korean J Hepatol 11 4 (2005) 381-385
94. Cedron Cheng H., Piscoya Rivera A., Bussakkeu Rivera A., et al. [Severe hypoglycemia as first manifestation hepatocarcinoma in pregnancy: case report]. Rev Gastroenterol Peru 25 2 (2005) 206-209 [in Spanish]
95. de la Rosa M.A., Nicolás-Pérez D., Muñiz-Montes J.R., et al. Evolution and management of a hepatocellular carcinoma during pregnancy. J Obstet Gynaecol Res 32 4 (2006) 437-439
96. De Maria N., Manno M., and Villa E. Sex hormones and liver cancer. Mol Cell Endocrinol 193 (2002) 59-63
97. Leyendecker J.R., Gorengaut V., and Brown J.J. MR imaging of maternal diseases of the abdomen and pelvis during pregnancy and the immediate postpartum period. Radiographics 24 5 (2004) 1301-1316
98. Pelsang R.E. Diagnostic imaging modalities during pregnancy. Obstet Gynecol Clin North Am 25 2 (1998) 287-300
99. Lau W.Y., Leung W.T., Ho S., et al. Hepatocellular carcinoma during pregnancy and its comparison with other pregnancy-associated malignancies. Cancer 75 11 (1995) 2669-2676
100. Mass K., Quint E.H., Punch M.R., et al. Gynecological and reproductive function after liver transplantation. Transplantation 62 4 (1996) 476-479
101. McKay D.B., Josephson M.A., Armenti V.T., et al. Reproduction and transplantation: report on the AST Consensus Conference on Reproductive Issues and Transplantation. Am J Transplant 5 7 (2005) 1592-1599
102. McKay D.B., and Josephson M.A. Pregnancy in recipients of solid organs-effects on mother and child. N Engl J Med 354 12 (2006) 1281-1293
103. Wu A., Nashan B., Messner U., et al. Outcome of 22 successful pregnancies after liver transplantation. Clin Transplant 12 5 (1998) 454-464
104. Rayes N., Neuhaus R., David M., et al. Pregnancies following liver transplantation-how safe are they? A report of 19 cases under cyclosporine A and tacrolimus. Clin Transplant 12 5 (1998) 396-400
105. Carr D.B., Larson A.M., Schmucker B.C., et al. Maternal hemodynamics and pregnancy outcome in women with prior orthotopic liver transplantation. Liver Transpl 6 2 (2000) 213-221
106. Armenti V.T., Herrine S.K., Radomski J.S., et al. Pregnancy after liver transplantation. Liver Transpl 6 6 (2000) 671-685
107. Miller J.C., Mastrobattista J.M., and Katz A.R. Obstetrical and neonatal outcome in pregnancies after liver transplantation. Am J Perinatol 17 6 (2000) 299-302
108. Christopher V., Al-Chalabi T., Richardson P.D., et al. Pregnancy outcome after liver transplantation: a single-center experience of 71 pregnancies in 45 recipients. Liver Transpl 12 7 (2006) 1138-1143